Nasdaq-listed Predictive Oncology launches $344M DePIN treasury focused on Aethir

Predictive Oncology (POAI), a biotechnology company specializing in AI-driven cancer research, has revealed a $344.4 million digital asset treasury centered on Aethir’s ATH token. This initiative marks the first instance of a Nasdaq-listed firm holding and managing tokens from a Decentralized Physical Infrastructure Network (DePIN). The strategy, developed with input from a Web3 investment company and BTIG, combines cash investments with a crypto PIPE for ATH tokens. This allows Predictive Oncology to classify tokenized DePIN infrastructure as a balance sheet asset. Following the announcement, the company’s shares surged over 70%, reaching their highest level since March, after struggling as a penny stock with minimal revenue. The ATH token, currently trading under $0.06, saw a 330% increase in trading volume post-announcement. Predictive Oncology joins a wave of smaller firms adopting digital asset treasury strategies, akin to other publicly traded companies integrating crypto assets into their balance sheets, despite caution regarding potential valuation pressures in the market.

Source 🔗